Point72 Ventures has led a $90m series C round for Shield AI, whose leadership includes Carnegie Mellon University’s associate research professor Nathan Michael.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

South China University of Technology spinout POI-Tech is working on industrial internet applications and will use some of the money to expand R&D activities.

Centessa has been formed as a biotech conglomerate with $250m in funding following a ten-way merger, including multiple spinouts.

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

University of Oxford and OSI have both returned for a $95.4m series C round that also included GV and, through the conversion of a note, Eli Lilly.

Amadeus Capital Partners has bought a stake in the University of Oxford spinout through a secondary transaction, valuing it at around $2.4bn.

The Johns Hopkins University spinout’s latest funding will go toward further developing its lead candidate, VTA-110, for muscular dystrophy treatments.

The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.